Venture
Allotera Therapeutics, Inc.
Latest Form D 2026-07-23- CIK 1874298
- State MO
- Other Health Care
- 3 Form D offerings since 2021-07-23
- Total sold
- $259M
- across 3 offerings
- Rounds
- 3
- Form D offerings since 2021-07-23
- Latest round
- $123M
- 2025-09-08 · 021-556954
- Investors
- 20
- on the latest round
Connected
named in its Form D filingsOfferings · since 2021-07-233 Form D offeringsExemptions506(b)People · Item 3Niall O'Donnell + 10 moreInvestors · dashboard1 inferred investor
Allotera Therapeutics, Inc.CIK 1874298
Round timeline
amount sold · by first filed2025-09-08 · $123M
- 2021-07-23$37.2M021-407570
- 2021-07-23$98.5M021-407610
- 2025-09-08$123M021-556954
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($123M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-556954 | First filed2025-09-08 | Latest2026-07-23 | Sought$163M | Sold$123M | Investors20 | Exemptions506(b) |
| 021-407610 | First filed2021-07-23 | Latest2021-07-23 | Sought$172M | Sold$98.5M | Investors27 | Exemptions506(b) |
| 021-407570 | First filed2021-07-23 | Latest2021-07-23 | Sought$37.2M | Sold$37.2M | Investors6 | Exemptions506(b) |
Who backs Allotera Therapeutics, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-07-23
| Name | Relationship |
|---|---|
| Niall O'Donnell | RelationshipDirector |
| Bali Muralidhar | RelationshipDirector |
| Peter Kiener | RelationshipDirector |
| Drew Dennison | RelationshipDirector |
| Kevin Li | RelationshipDirector |
| Bosun Hau | RelationshipDirector |
| Matthew Cooper | RelationshipExecutive Officer |
| Ayman Kabakibi | RelationshipExecutive Officer |
| Natalie Mount | RelationshipDirector |
| Kumar Srinivasan | RelationshipExecutive Officer, Director |
| Cherry Thomas | RelationshipExecutive Officer |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- Missouri (MO)
- Exemptions
- Rule 506(b)
- First filed
- 2021-07-23
- Latest filing
- 2026-07-23
Who backs Allotera Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗